Fulminant liver failure in rats causes significant changes in opioid peptide levels across multiple brain regions and plasma, supporting the use of opioid antagonists to treat hepatic encephalopathy.
4 peptides altered across brain regionsMet-enkephalin, Leu-enkephalin, dynorphin A, and beta-endorphin all showed significant changes in liver failure
What the researchers found
Fulminant hepatic failure significantly altered Met-enkephalin, Leu-enkephalin, dynorphin A, and beta-endorphin levels in multiple brain regions and plasma.
Why it matters
This study provided direct evidence that liver failure disrupts the brain's opioid peptide system, helping explain the neurological symptoms of hepatic encephalopathy and justifying opioid antagonist treatment.
How the study worked
Rats were given thioacetamide to induce fulminant hepatic failure. Opioid peptide levels were measured in discrete brain regions and plasma using radioimmunoassay and compared to healthy controls.
What this study cannot tell us
Animal study using chemically induced liver failure, which may not perfectly replicate human hepatic encephalopathy. The causal relationship between altered opioid levels and neurological symptoms was not directly established.
How to read the evidence
Moderate animal evidence with systematic measurement across brain regions. Provides mechanistic support for clinical use of opioid antagonists in hepatic encephalopathy.
When this study was published
Published in 1995, this study contributed to the evidence base for using naloxone and similar drugs in hepatic encephalopathy treatment.
The bigger picture
Understanding how liver failure affects brain opioid peptides has clinical implications for treating the millions of patients worldwide who develop hepatic encephalopathy from cirrhosis or acute liver failure.
Questions still open
- Could monitoring opioid peptide levels help predict or stage hepatic encephalopathy?
- Which specific opioid receptor subtypes should be targeted for optimal treatment of hepatic encephalopathy?
Common questions
What is hepatic encephalopathy?
Why would opioid blockers help liver disease patients?
Read the original research
Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists.
The Journal of pharmacology and experimental therapeutics, 273(1), 185-92
Citation
Yurdaydin, C; Li, Y; Ha, J H; Jones, E A; Rothman, R; Basile, A S. (1995). Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists.. The Journal of pharmacology and experimental therapeutics, 273(1), 185-92.